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Abstract
Many types of epileptic seizures are characterized by generalized spike-and-wave discharges. In the past, notable effort has
been devoted to understanding seizure dynamics and various hypotheses have been proposed to explain the underlying
mechanisms. In this paper, by taking an integrative view of the underlying mechanisms, we demonstrate that epileptic
seizures can be generated by many different combinations of synaptic strengths and intrinsic membrane properties. This
integrative view has important medical implications: the specific state of a patient characterized by a set of biophysical
characteristics ultimately determines the optimal therapeutic treatment. Through the same view, we further demonstrate
the potentiation effect of rational polypharmacy in the treatment of epilepsy and provide a new angle to resolve the debate
on polypharmacy. Our results underscore the need for personalized medicine and demonstrate that computer modeling
and simulation may play an important role in assisting the clinicians in selecting the optimal treatment on an individual
basis.
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Introduction
Generalized spike-and-wave (SW) patterns of the electroenceph-
alogram (EEG) are typically observed during many types of epileptic
seizures, in particular, during absence seizures, which are character-
ized by clear-cut spike-and-wave EEG oscillations. The mechanisms
underlying spike-and-wave patterns are complex and may involve
cerebral cortex and thalamus, intrinsic properties of neurons, and
various types of synaptic receptors present in the circuit. There has
been notable effort devoted to understanding seizure dynamics and
various hypotheses have been proposed to explain the underlying
mechanisms [1,2]. Some studies [3–7] demonstrate that synaptic
receptors are especially important in the generation of epileptic
seizures while others believe intrinsic properties of neurons play an
important role [8–14]. While each of such hypotheses is supported by
some experimental evidence, they tend to only cover a small subset of
underlying causes and may even appear contradictory to each other.
It is well known in the field of neuroscience that virtually
indistinguishable network activities may arise from widely
disparate sets of underlying mechanisms [15–17]. As far as
spike-and-wave oscillations are concerned, it is not difficult to
foresee the existence of a complex parameter landscape. In this
paper, a thalamocortical model is developed based on [5,7] to
encompass key interplays between the thalamus and cortex as well
as within the cortex through inhibitory, excitatory synaptic
receptors and intrinsic currents.
The first half of the paper is devoted to understanding the
interplay of various mechanisms underlying generalized spike-and-
wave epileptic seizures by taking an integrative view. To achieve
this goal, we first study the interplay of inhibitory and excitatory
receptors on specific synaptic connections and our results
demonstrate that: (1) although both GABAA and GABAB
receptors are actively involved in seizure generation, they play
quite different roles: while the former typically inhibits seizure
activity, the latter actually induces the absence-like seizure activity;
(2) while intuition may suggest that increased excitation would
cause seizures, the interplay of AMPA-type glutamate receptors
can be complex and seizures may even be generated by decreased
excitation; (3) intrinsic properties of neurons also have a significant
impact on seizure generation. In addition to the roles of specific
synaptic connections, the global role played by a given type of
synaptic receptor in the whole network is also studied. We
demonstrate how network behavior is influenced by changes in the
efficacy of all the synapses mediated by the same type of receptor.
The results have direct implications on the study of drug treatment
of epilepsy. Finally, we performed one million simulations to show
the interplay of multiple mechanisms in a high dimensional
parameter space. For each simulation, all the synaptic conduc-
tances were randomly generated following a unform distribution
within specified ranges. The distribution of the simulation results
demonstrates that both spindle and spike-and-wave activities can
be produced by a huge number of parameter combinations and
both activities cover the full range of tested values of all the
synapses.
In the second half of the paper, we study the implications of the
integrative view of mechanisms underlying epileptic seizures on
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network, the underlying parameter combinations form a complex
parameter set in the high-dimensional parameter space, where
each point in the parameter set of spike-and-wave oscillations can
be considered as a specific pathological instance, which corresponds to
a particular individual suffering from epilepsy. There has been
widespread debate about the effect of polypharmacy for the
treatment of epilepsy [18]. While some researchers think that the
combination of two low-dose drugs generates a greater therapeutic
effect with less risk of toxicity than a larger dose of a single drug
[19–23], others believe that a full dose of one drug achieves better
control of seizures with fewer adverse effects [24–28]. In this
paper, we provide a more complete picture and show that the
location of each pathological instance in the parameter space is an
important factor to consider when determining the best treatment
with the minimal drug dose. To provide a quantitative assessment
of the optimal therapeutical treatment, we formulate and solve a
mathematical optimization problem.
Our results in the second part of the paper show that: (1) the
optimal treatment is a function of the state of individual patients as
well as the potency of the candidate drugs; (2) the potentiation of
rational polypharmacy for drugs with complementary receptors
can be explained by the non-linearity of the drug-response
characteristics; (3) while monopharmacy is optimal for the
majority of patients, rational polypharmacy is required by a small
portion of patients represented by pathological instance points
located deeply inside the pathological regime in the parameter
space. (4) our study foresees the benefits of personalized medicine,
a practice in which computer modeling and simulation assist the
clinicians in determining the optimal treatment on an individual
basis.
Results and Discussion
An illustration of the thalamocortical network, its synaptic
connectivity and the basic network model with eight cells are
shown in Fig. 1. The thalamus is modeled by the thalamic reticular
(RE) and thalamocortical (TC) cells, and the deep layers of the
cortex are represented by the pyramidal (PY) and interneurons
(IN) cells. This simple eight cell model is proven to be able to make
predictions for larger networks with similar structures [7] (see
details in Materials and Methods).
Fig. 2 shows the firing activities of different types of neurons and
field potentials of the network in the transition from spindles to
spike-and-wave by blocking synaptic GABAA receptors in cerebral
cortex at t~2s.
In the first two seconds of the simulation, the network is in the
control condition and generates the typical synchronized spindle
oscillations at about 10 Hz. Exemplary firing patterns of the cells
are shown in Fig. 2, where the TC cells discharge once every two
cycles and all other cells discharge in every cycle. These simulated
activities are consistent with typical spindle oscillations observed
experimentally [29,30]. The corresponding field potentials are
shown in Fig. 2I (in the first two seconds of the simulation), which
are characterized by successive negative deflections at a frequency
of about 10 Hz.
Starting from 2 seconds, as the synaptic GABAA receptors in
cerebral cortex are blocked(gGABAA(IN?PY)~0), the network transits
from the spindle oscillations to a slower oscillation mode (v4 Hz)
with field potentials characterized by large-amplitude negative
spikes and small-amplitude positive waves. The spike-and-
wave(SW) patterns are typically observed during epileptic seizures.
In the last two seconds of simulation in Fig. 2, all the cells fire
prolonged high-frequency discharges synchronously during the
negative spikes and the positive waves are coincident with the
silent periods of all the cells. This portrait is typical of experimental
recordings of cortical and thalamic cells with the SW oscillation
pattern.
All the values of parameters in the control condition are
provided in Materials and Methods. In the following sections, the
default value of the control condition is chosen for each parameter
unless stated otherwise.
An integrative view of mechanisms underlying
generalized spike-and-wave epileptic seizures
In the previous demonstration, the transition from spindles to
SW is obtained by blocking GABAA receptors in the cortex.
However, the transition can also be triggered by alterating other
parameters. Indeed, the activities of the network (spindles, SW,
etc.) are determined by the combination of a large number of
parameters including both synaptic receptors and intrinsic
currents of neurons. In this section, we take an integrative view
of various mechanisms underlying generalized spike-and-wave
epileptic seizures and demonstrate that the epileptic activities are
resulted from the interplay of a large number of underlying
parameters.
Before proceeding further, we first classify the typical behaviors
of the network into one of the five categories:
(1) RT (resting mode): resting state.
(2) SP (spindle): 7–15 Hz oscillation; PY cells generate a few
spikes per cycle, and the field potential consists of successive
positive and negative deflections.
(3) DE (delta): 1–4 Hz oscillation; PY cells generate a few spikes
per cycle, and the field potential consists of successive positive
and negative deflections similar to that of spindles but at lower
frequencies.
(4) SW (spike-and-wave): 1–4 Hz oscillation; PY cells generate
prolonged firing per cycle, and the field potential consists of
large-amplitude negative spikes and small-amplitude positive
waves.
(5) EF (extreme prolonged firing): an extreme case of prolonged
firing; due to overwhelming excitation, such prolonged firing
will continue forever.
The firing activities and field potentials in different modes of the
network are shown in Fig. 3. Generally speaking, as the balance
between excitation and inhibition shifts towards excitation, the
modes of the network tend to shift from (1) to (5) accordingly. Note
that, the resting state of the brain is only a ‘‘theoretical mode’’ in
the study, which does not really exist. In reality, neurons are
always active one way or the other due to external sensory inputs,
more intrinsic membrane properties, and many other possible
mechanisms.
In the following sections, RT, SP, DE, SW, and EF will be used
to denote the corresponding behaviors as defined above.
Interplay of GABA-mediated inhibitions. Gamma-amino-
butyric acid(GABA) is the chief inhibitory neurotransmitter in the
central nervous systems vertebrates. There are two classes of
GABA receptors: GABAA receptor (ligand-gated ion channels),
which responds fast to GABA, and GABAB receptor (G protein-
coupled receptors), which responds slowly to GABA. Although
both are important in seizure generation, they are playing quite
different roles. While GABAA receptor is generally believed to
inhibit seizure activity, GABAB receptor has been shown to induce
absence seizure like activity [31–34]. As a result, while many anti-
absence drug (clobazam, clonazepam, pheobarbital, primidone,
Integration of Epileptic Mechanism and Implication
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antagonists hold the promise as anticonvulsants for absence
seizures.
The role of GABAA-mediated inhibition, GABAA(IN?PY), was
initially demonstrated in Fig. 2. In this section, we extend our
studies to two more important GABA-mediated inhibitions in the
thalamus: intra-RE GABAA-mediated inhibition GABAA(RE?RE)
and intrathalamic GABAB-mediated inhibition GABAB(RE?TC).
While some key properties were studied in [5], we provide a more
complete picture by examining the interplay between the two
inhibitions and GABAA(IN?PY).
Intra-RE GABAA-mediated inhibition: GABAA(RE?RE). As
shown in Fig. 4A, the parameter space of gGABAA(IN?PY) and
gGABAA(RE?RE) is divided into four regions characterized by different
modes of network behavior. When gGABAA(IN?PY) is small, the
network is in the mode of SW. When gGABAA(IN?PY) is large, the
network successively displays the modes of DE, SP, and RT as
gGABAA(RE?RE) increases. The transition from SP to DE made by
blocking GABAA(RE?RE) was demonstrated in the study of [5],
which is in agreement with in vivo injections of bicuculline into the
thalamus [30]. This suggests that, given a large gGABAA(IN?PY), the
suppression of GABAA(RE?RE) may only affect the oscillation
frequency but does not generate SW because the pyramidal cells
are still under the control of GABAA(IN?PY).
With the more complete picture in Fig. 4A, it is evident that
while both DE and SP can be transited into SW by decreasing
GABAA(IN?PY), it is easier to generate epileptic seizures starting
from DE. Moreover, for fixed GABAA(IN?PY), epileptic seizures
are easier to occur with less GABAA(RE?RE). As a result,
reinforcing GABAA(RE?RE) could reduce the tendency to generate
epileptic seizures, which is in agreement with the presumed role of
anti-absence drug clonazepam [35]. Note that, while a moderate
increase of GABAA(RE?RE) can resist the occurrence of epileptic
seizures, Fig. 4A also indicates that too much GABAA(RE?RE) may
drive the network into RT and thus affect the normal function of
the brain.
Intrathalamic GABAB-mediated inhibition: GABAB(RE?TC). In
additiontoGABAA(RE?RE),GABA B(RE?TC) isalsobelievedtoplayan
importantroleinthegenerationofepilepticseizuresduetothenonlinear
responsepropertyofGABAB typereceptors[7,33].AsshowninFig.4B,
the parameter space of gGABAA(IN?PY) and gGABAB(RE?TC) includes two
regions: SW and SP. It is clear that reducing gGABAB(RE?TC) significantly
diminishes SW in favor of SP, and increasing the conductance has the
oppositeeffect.Especially,whengGABAB(RE?TC) is0,thethalamuscannot
berecruitedintothemodeofsloweroscillationevenifGABAA(IN?PY) is
suppressed to zero. This agrees with the fact that GABAB antagonists
have been found useful in preventing the development of SW in some
animal models [33].
Studies based on the current model suggest that the generation
of epileptic seizures needs the involvement of both cortex and
thalamus [7]. Thalamus plays an important role as it can oscillate
at low frequencies (v4 Hz) due to the post-inhibitory rebound
bursting property of TC cells. TC cells are capable of firing a burst
of action potentials in response to inhibitions from RE cells,
mediated by both GABAA and GABAB. The slowly activated
GABAB receptors make it possible for thalamus to perform
oscillations at low frequencies (v4 Hz). As a result, with
GABAB(RE?TC) available, an epileptic seizure can be triggered
by suppressing GABAA(IN?PY). Otherwise, as demonstrated in
Fig. 4B, the seizure will not happen even if GABAA(IN?PY) is
suppressed to zero.
In addition, recent studies have also suggested the neocortical
origin of spike-and-wave field potentials in experimental models of
absence seizure [36,37]. Without thalamic participation, intrinsic
rebound mechanisms of cortical cells as those in TC cells may be
necessary in order to generate sustained spike-and-wave oscilla-
tions. One such candidate is the low-threshold spike (LTS)
pyramidal cells in cerebral cortex, which could respond to
hyperpolarization with a burst of action potentials. With LTS
PY cells, there is a loop inside the cortex: PY cells excite IN cells,
IN cells inhibit LTS PY cells, and LTS PY cells produce rebound
burst firings to start the next cycle of the sustained oscillation.
Computational studies [38] have demonstrated that spike-and-
wave oscillations can be generated in a network of cortical
neurons, where 5% of PY cells are LTS PY cells. In the current
work, we study the role of thalamocortical loops in epileptic
Figure 1. Thalamocortical network model.
doi:10.1371/journal.pone.0022440.g001
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current model.
Interplay of AMPA-mediated excitations. While the
earlier studies of [5,7] focused on inhibitory receptors, AMPA-
type glutamate receptors, which mediate fast excitatory
neurotransmission, also play an important role in the generation
of epileptic seizures. Several antiepileptic drugs are designed as
AMPA antagonists like talampanel and perampanel [39,40].
While intuition may suggest that increased excitation would
cause seizures, the interplay of AMPA-mediated excitations could
be complex and seizures could even be generated by decreased
excitations. This implies that special caution should be taken in the
drug design process. To illustrate this point, the interplay of two
intracortical AMPA-mediated excitations, AMPA(PY?PY) and
AMPA(PY?IN) are studied in this section.
Intra-PY AMPA-mediated excitation: AMPA(PY?PY). While
suppressing gGABAA(IN?PY) h a sb e e ns h o w nt ob ea ne f f e c t i v ew a yt o
generate seizure, Fig. 5A indicates an alternative path to seizure by
increasing excitation AMPA(PY?PY). The modes of the network are
determined by the balance between excitation and inhibition
characterized by the relative strengths of gAMPA(PY?PY) and
gGABAA(IN?PY). Generally speaking, reducing gAMPA(PY?PY) or
increasing gGABAA(IN?PY) can significantly diminish SW in favor of
SP, and increasing gAMPA(PY?PY) or reducing gGABAA(IN?PY) has the
opposite effect. This also indicates that anti-absence drugs may be
designed as AMPA antagonists. Note that, as shown in the upper part
Figure 2. The firing activities of different types of neurons and field potentials in the transition from spindles to spike-and-wave by
blocking synaptic GABAA receptors in cerebral cortex at t~2s. (A) Firing activities of the first pyramidal cell (PY). (B) Firing activities of the first
interneuron (IN). (C) Firing activities of the second pyramidal cell (PY). (D) Firing activities of the second interneuron (IN). (E) Firing activities of the first
reticular cell (RE). (F) Firing activities of the first thalamocortical cell (TC). (G) Firing activities of the second reticular cell (RE). (H) Firing activities of the
second thalamocortical cell (TC). (I) Field potentials.
doi:10.1371/journal.pone.0022440.g002
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transited into SW even if GABAA(IN?PY) is suppressed to zero.
PY-to-IN AMPA-mediated excitation: AMPA(PY?IN). Alth-
ough both are excitatory, different from AMPA(PY?PY),
AMPA(PY?IN) plays an opposite role. Intracortically, the firing
of PY cells results in excitatory postsynaptic potentials on both PY
and IN cells due to AMPA(PY?PY) and AMPA(PY?IN),
respectively. While the former contributes to the excitation of
PY cells directly, the latter enhances the activity of IN cells, which
produce inhibitory postsynaptic potentials on PY cells. Therefore,
AMPA(PY?IN) contributes to the inhibition of PY cells indirectly.
As shown in Fig. 5B, increasing gAMPA(PY?IN) diminishes SW in
favor of SP.
While it is generally true that the suppression of gAMPA(PY?IN)
may lead to epileptic seizures, the suppression of both
AMPA(PY?IN) and AMPA(PY?PY) can also lead to epileptic
seizures. The parameter space of gAMPA(PY?PY) and gAMPA(PY?IN) is
shown in Fig. 6A. If gAMPA(PY?IN) and gAMPA(PY?PY) are decreased
‘‘proportionally’’, the network will remain in SP (solid arrow).
However, if the decreases of the two conductances are out of
proportion, it is possible for the network to transit from SP to SW
(dashed arrow). The field potentials of the starting point and the
ending points of both arrows are shown in Fig. 6B, Fig. 6C, and
Fig. 6D, respectively.
This complex interplay between AMPA-mediated excitations
demonstrates another path to seizure, which is different from the
common notion that the seizure is caused by an increase of the
strength of excitatory synapses. Similar results were reported in
computational studies [41,42] and supported by experimental
observations [43]. These results suggest that special caution should
be taken in the drug design process.
Cellular mechanisms of intrinsic currents. Intrinsic
membrane currents affect the network-level oscillatory behavior
in an important way. In the study of [5,7], a small set of ion
channels are used to characterize pyramidal cells which generate
the regular spiking pattern. Nevertheless, there exists a wide
Figure 3. Firing activities and field potentials in different modes of the network. (A) Firing activities of pyramidal cells in resting mode (RT).
(B) Firing activities of pyramidal cells in the mode of spindle oscillation (SP). (C) Firing activities of pyramidal cells in the mode of delta oscillation (DE).
(D) Firing activities of pyramidal cells in the mode of spike-and-wave (SW). (E) Firing activities of pyramidal cells in the mode of extreme prolonged
firing (EF). (F) Field potentials in resting mode (RT). (G) Field potentials in the mode of spindle oscillation (SP). (H) Field potentials in the mode of delta
oscillation (DE). (I) Field potentials in the mode of spike-and-wave Mode (SW). (J) Field potentials in the mode of extreme prolonged firing (EF).
doi:10.1371/journal.pone.0022440.g003
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important roles in the generation of seizures [8–14]. Especially,
some of the ion channels are important targets for anti-epileptic
drug design. Towards a more complete understanding of the effect
of intrinsic membrane currents, we introduce several key ion
channels to the model and demonstrate the interplay between
synapses and intrinsic membrane properties of neurons.
Persistent Naz current: INaP. One important intrinsic
current to consider is the persistent Naz current INaP. INaP is a
small slowly-inactivating Naz current with kinetics of inactivation
in tens of seconds. This current may amplify synaptic potentials,
generate subthreshold oscillations, facilitate repetitive firing, and
maintain prolonged depolarized potentials. As epilepsy is
associated with INaP of an amplitude several times larger than
typically observed under the normal physiological conditions, INaP
is believed to contribute to the pathophysiological
hyperexcitability associated with the disorder. As shown in
Fig. 7A, the parameter space of gGABAA(IN?PY) and gNaP is
divided into four regions: SW, SP, EF, and high frequency
oscillation (which oscillates at higher frequencies than spindles due
to the existence of NaP). As gNaP increases, the region of SW
expands significantly. This implies that epileptic seizures may
happen even with strong inhibition if the excitation is enhanced by
the activation of INaP. As a result, the persistent sodium current is
a common target of anti-epileptic drugs, and can be reduced by a
wide variety of anti-epileptic drugs [44–48].
Figure 4. The interplay of GABA-mediated inhibitions in the generation of epileptic seizures. (A) Oscillation frequency as a function of
maximal synaptic conductance gGABAA(IN?PY) (X-axis) and maximal synaptic conductance gGABAA(RE?RE) (Y-axis). (B) Oscillation frequency as a function of
maximal synaptic conductance gGABAA(IN?PY) (X-axis) and maximal synaptic conductance gGABAB(RE?TC) (Y-axis).
doi:10.1371/journal.pone.0022440.g004
Figure 5. The effect of AMPA-mediated excitations in the generation of epileptic seizures. (A) Oscillation frequency as a function of
maximal synaptic conductance gGABAA(IN?PY) (X-axis) and maximal synaptic conductance gAMPA(PY?PY) (Y-axis). (B) Oscillation frequency as a function of
maximal synaptic conductance gAMPA(PY?IN) (X-axis) and maximal synaptic conductance gGABAA(IN?PY) (Y-axis).
doi:10.1371/journal.pone.0022440.g005
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current that plays a similar role is the high-threshold calcium
current ICaH. Similar to INaP, ICaH is also slowly inactivating. The
key difference between the two is that ICaH is activated only at a
higher threshold voltage and thus is often triggered by action
potentials. After activation, it contributes significantly to the
depolarization of the membrane, thus amplifies synaptic potentials
and maintains prolonged depolarized potentials. The parameter
space of gGABAA(IN?PY) and gCaH is depicted in Fig 7B, where the
region of SW expands significantly as gCaH increases. Some anti-
epileptic drugs have been proposed to antagonize high-threshold
calcium channels including phenytoin [49], carbamazepine [50],
topiramate [51], etc.
M-current: IM. So far, we have demonstrated the effects of
two intrinsic currents, which serve as enhancers of neuronal
excitability. On the other hand, some other intrinsic currents may
play different roles in determining the mode of network oscillation.
One such intrinsic current is the M-current IM, which is a slowly
activating potassium current. The most important feature of IM is
that a significant amount of this current is on near the resting
potential. As a result, IM usually acts as a damper on neuronal
excitability. As shown in the parameter space of gGABAA(IN?PY) and
gM depicted in Fig 7C, gM has the similar effect of gGABAA:
increasing gM diminishes SW in favor of SP and decreasing the
conductance has the opposite effect. As a result, M current can
also be a target of anti-epileptic drugs. For example, retigabine
(and ICA-27243) enhances M-current activation through the
voltage-gated Kz channel Kv7:2 (also known as KCNQ2) [39,52].
Afterhyperpolarization current: IAHP. Another important
intrinsic current is the afterhyperpolarization current IAHP, which
is a potassium current activated by the calcium current during an
action potential. Due to the non-inactivating property and large
time constant, the amount of IAHP activated by bursts of action
potentials is easily accumulated and produces long-lasting
hyperpolarizations after the burst. As a result, IAHP can play the
role of the GABAB current IGABAB(IN?PY) in generating long-lasting
hyperpolarizations associated with the ‘waves’ component of SW.
To demonstrate this, we add IAHP to the model and set
gGABAB(IN?PY)~0 to disable the cortical GABAB receptors. The
parameter space of gGABAA(IN?PY) and gAHP is depicted in Fig. 7D.
When gGABAA is large, the network is in the mode of SP. When
gGABAA is small, the network has two different modes: SW and EF.
As gAHP decreases, the balance between excitation and inhibition
shifts towards the former. As a result, the range of SW decreases
while the range of EF increases.
The interplay of mechanisms of different types. The
interplays of a number of parameters have been studied pairwise
in the previous sections. Those parameters can be divided into
three groups: inhibitory synapses, excitatory synapses, and intrinsic
ion channels, which have been widely found in many parts of the
brain.
The roles of synaptic connections with specific presynaptic and
postsynaptic neurons have been demonstrated. In addition to
studying such specific synaptic connections, it is also important to
study the global role played by a given type of synaptic receptor in
the whole network. It is interesting to see how network behavior is
influenced by changes in the efficacy of all the synapses mediated
by the same type of receptor. It has direct implications on the
study of drug treatment of epilepsy. For example, if an AMPA
antagonist is applied, instead of a specific AMPA-mediated
synapse, the strength of all the AMPA-mediated synapses in the
network will be decreased.
In this section, we use AMPA and GABAA receptors together
with persistent sodium ion channels as an example to study the
global roles played by different synaptic receptors and ion
channels in the whole network. In this study, the strength of all
the AMPA-mediated synapses, GABAA-mediated synapses, and
persistent sodium ion channels will be scaled by a factor of
kAMPA[½0:5,1:5 , kGABAA[½0:5,1:5 , and kNaP[½0,1 , respectively.
As a result, the scaled maximum conductances of all the AMPA
receptor channels, GABAA receptor channels, and persistent
sodium ion channels will be in the ranges of ½0:5,1:5 xAMPA,
½0:5,1:5 xGABAA, and ½0,1 xNaP, respectively, where xAMPA and
xGABAA represent the corresponding values in the control
condition and xNaP~0:5mS=cm2.
The three scale factors are used as parameters and the
corresponding parameter space is depicted in Fig. 8A, where the
Figure 6. The suppression of both synaptic excitations in cortex in the generation of seizures. (A) Oscillation frequency as a function of
maximal synaptic conductance gAMPA(PY?IN) (X-axis) and maximal synaptic conductance gAMPA(PY?PY) (Y-axis). If gAMPA(PY?IN) and gAMPA(PY?PY) are
decreased ‘‘proportionally’’, the network will remain in SP (solid arrow). However, if the decreases of the conductances are out of proportion, it is
possible for the network to transit from SP to SW (dashed arrow). (B) The field potential of the starting point of both arrows (gAMPA(PY?PY)~0:6mS,
gAMPA(PY?IN)~0:4mS). (C) The field potential of the ending point of the dashed arrow (gAMPA(PY?PY)~0:5mS, gAMPA(PY?IN)~0mS). (D) The field potential
of the ending point of the solid arrow (gAMPA(PY?PY)~0mS, gAMPA(PY?IN)~0mS). The results in Fig. 6 are obtained with gGABAA(IN?PY)~0:0187mS.
doi:10.1371/journal.pone.0022440.g006
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modes of network oscillation: a pathological regime Spathological
characterized by the spike-and-wave oscillation pattern as shown
in Fig. 8B, and a physiological regime Sphysiological characterized by
spindles as shown in Fig. 8C, respectively. The state of the network
is determined by the interplay of three scale factors. Generally
speaking, if the overall effect of excitation (kAMPA enhanced by
kNaP) is more dominant than that of inhibition (kGABAA), the state
of the network is in the pathological regime. Otherwise, the state is
in the physiological regime. Increasing kGABAA, decreasing kNaP,
or decreasing kAMPA can diminish SW in favor of spindles.
The interplay of multiple mechanisms in a high
dimensional parameter space. So far, we have only
considered analysis with two or three parameters. In this section,
we show the interplay of all the synaptic receptors in the network in
a twelve-dimensional parameter space. The maximum
conductances of the twelve synaptic receptor channels in the
networkarevariedin the range of ½0:5,1:5 x, wherex represents the
corresponding maximum conductances in the control condition.
One million simulations are run and for each simulation all the
parameters are randomly generated following a unform distribu-
tion within the ranges specified. Spectrum analysis is used after
each simulation to obtain the most dominant harmonic compo-
nent of the time-domain waveform of the field potentials. Fig. 9
shows the distribution of the simulation results in terms of the
dominant frequencies. As shown in Fig. 9, most simulation results
fall into the ranges of either 7–15 Hz oscillation or 1–4 Hz
oscillation. In addition, while the former is mostly represented by
blue or green colors, the latter is mostly represented by red or
yellow colors. This means that the magnitudes of most 1–4 Hz
oscillations are one or two orders larger than the magnitudes of 7–
15 Hz oscillations.
Figure 7. Cellular mechanisms of intrinsic currents. (A) Oscillation frequency as a function of the maximum conductance of persistent sodium
gNaP (X-axis) and the maximal synaptic conductance gGABAA(IN?PY) (Y-axis). (B) Oscillation frequency as a function of the maximal conductance of high
threshold calcium gCaH (X-axis) and the maximal synaptic conductance gGABAA(IN?PY) (Y-axis). (C) Oscillation frequency as a function of the maximum
conductance of M-current gM (X-axis) and the maximal synaptic conductance gGABAA(IN?PY) (Y-axis). (D) Oscillation frequency as a function of the
maximal conductance of afterhyperpolarization current gAHP (X-axis) and the maximal synaptic conductance gGABAA(IN?PY) (Y-axis). The results in
Fig. 7D are obtained with gCaH~0:4mS=cm2.
doi:10.1371/journal.pone.0022440.g007
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magnitudes (green) represent spindle oscillations (SP), the 7–
15 Hz oscillations with small magnitudes (blue) represent the
resting mode (RT) (after few cycles of spindle oscillation at the
initial stage, the network returns to resting state due to strong
inhibition), the 1–4 Hz oscillations with small magnitudes (green)
represent delta oscillations (DE), and the 1–4 Hz oscillations with
large magnitudes (red and yellow) represent spike-and-wave
activities (SW).
Among one million simulations, there are a total of 193,624 SW
activities. The distribution of SW activities in terms of the strength
of each of the twelve synapses in the network is shown in Fig. 10.
The SW activities cover the full range of tested values of all the
synapses and this is also true for spindle activities (not shown). As a
result, any synapse with strength in any of the five grade levels
could be associated with both pathological and physiological
regimes. This further demonstrates the important role played by
the combination of parameters in seizure generation. In addition,
compared with others, GABAA(IN?PY) and AMPA(PY?PY)
appear to be two critical factors in the range being tested. As
shown in Fig. 10A and Fig. 10C, as the strength of GABAA(IN?PY)
decreases or the strength of AMPA(PY?PY) increases, there are
more SW activities.
Fig. 11 shows the joint distribution of SW activities in terms of
the strength of the two critical parameters, GABAA(IN?PY) and
AMPA(PY?PY). As shown in Fig. 11, although most SW activities
occur when GABAA(IN?PY) is small and AMPA(PY?PY) is large,
there are a small number of SW activities (represented by the
rightmost deep blue bar in Fig. 11), which can even arise with
maximal strength of GABAA(IN?PY) and minimal strength of
AMPA(PY?PY). There are a total number of 247 such cases out of
193,624 SW activities.
The above results demonstrate that SW activities could arise
from a huge number of combinations of underlying parameters
and any parameter with values in the full range being tested could
be associated with both pathological and physiological regimes.
Although some parameters appear to be more critical than others,
there is no guarantee that those parameters will always play a
Figure 8. Pathological and physiological regimes in a three-dimensional parameter space. X-axis represents the scale factor of the
maximum conductances of persistent sodium channels, kNaP, Y-axis represents the scale factor of the maximal conductances of GABAA receptor
channels, kGABAA, and Z-axis represents the scale factor of the maximal conductances of AMPA receptor channels, kAMPA. (A) Pathological and
physiological regimes together. (B) Pathological regime. (C) Physiological regime.
doi:10.1371/journal.pone.0022440.g008
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strong nonlinearity and high complexity of neuron circuits, the
underlying mechanisms of SW activities are very complex.
Phase flow representations of oscillations. Phase flow
analysis has been successfully applied to macroscopic (mean field)
models, which are typically described by a few differential
equations. However, as the biophysical network model in this
paper is described by hundreds of differential equations, it is
infeasible to demonstrate a complete phase flow in such high
dimensional space. Nevertheless, as neural oscillations are of our
interest, two state variables are chosen to obtain phase flow in a
two-dimensional subspace: one such state variable is the field
potential, an indicator of network-level oscillations, and the other
state variable is the intracellular calcium concentration in a
reticular cell, an indicator of cellular-level subthreshold
oscillations.
From the resting state, the network may be entrained to
oscillation by applying a hyperpolarizing current step to a
thalamocortical cell. If the amplitude of the current step is small,
the network will display damped oscillation and return to rest in a
few cycles. However, if the pulse is large enough, the network will
display sustained oscillation. Typically, the sustained oscillation
would be either spindle or delta wave depending on the parameter
setting of the network. This indicates that there exit a stable
equilibrium point corresponding to the resting state and a stable
limit cycle corresponding to spindle or spike-and-wave oscillation.
Fig. 12 shows the phase flows of spindle and spike-and-wave
oscillations in the two-dimensional subspace. The spindle
oscillation is obtained from a 20-second simulation with the
parameters corresponding to the control condition. The spike-and-
wave oscillation is obtained with the same set of parameters except
that the conductance of GABAA receptors in cerebral cortex is set
to be 0. The phase flows in Fig. 12B and Fig. 12D demonstrate the
limit cycles corresponding to spindle and SW oscillations,
respectively.
To demonstrate the transition from spindle to spike-and-wave,
we use the conductance of GABAA receptors in cerebral cortex,
gGABAA(IN?PY), as the control parameter, in a 20-second simulation.
At each time step of 0:01ms, the conductance is decreased by
7:5|10{8mS. As a result, the control parameter undergoes
stepwise linear decay from an initial value of 0:15mS at time 0s to
0mS at time 20s. As shown in Fig. 13, the transition from spindle to
SW occurs at about 17:8s. The network is in the mode of spindle
oscillation before 17:8s and the amplitude of the limit cycle slightly
increases as gGABAA(IN?PY) decreases. As shown in Fig. 13D, the
oscillation frequency drops from 8Hz to 4Hz at about 17:8s and
the network switches into the other mode. In this mode, the
oscillation continues at lower frequencies and the amplitude of
limit cycle starts to grow dramatically as the control parameter
increases. The new mode corresponds to spike-and-wave oscilla-
tion. This transition is similar to a supercritical flip (period
doubling) bifurcation, which leads to the appearance of a new
cycle (SW) with a double period (in the vicinity of the original cycle
(spindle) in which the system has lost stability) [53].
The implication on optimal therapeutic treatments
For a given activity of the network, the underlying parameter
combinations form a complex parameter set in a high-dimensional
parameter space, where each point in the parameter set of SW
oscillations can be considered as a specific pathological instance,
which corresponds to a particular individual suffering from
epilepsy. As a result, the integrative view of mechanisms
underlying epileptic seizures has direct implications on the optimal
treatments of epilepsies.
To discuss the implication on optimal therapeutic treatments, in
this section, we first use simulation to show trajectory activities
modified by drug intervention, then introduce the dose-response
relationship, define a drug optimization problem, and finally
analyze results from the optimization.
Trajectory activities modified by drug intervention. In
this section, we show trajectory activities modified by drug
intervention. We perform 20-second simulations to demonstrate
that the spike-and-wave oscillation (seizure) could be switched
back to normal spindle oscillation by modifying different network
parameters with time gradually to mimic the effects of different
drugs. Initially, the network is set to be oscillating in SW mode
with gNaP~0:3mS=cm2 and all the other parameters
corresponding to the control condition. When a drug is applied,
we assume all the target synapses/ion channels in the network will
be proportionally affected.
First, we use the conductances of all the GABAA receptor
channels as the target parameters to reflect the effect of GABAA
agonists. In the simulation, all the target parameters linearly scale
up at each time step from an initial value of xGABAA at time 0s to
3xGABAA at time 20s, where xGABAA represents the target
parameter values in the control condition. As shown in Fig. 14A
and Fig. 14B, due to the increase of GABAA mediated inhibition,
the mode of the network is transited from SW back to spindle at
about 17s.
Second, we demonstrate the effect of AMPA antagonists with all
the conductances of AMPA receptor channels as the target
parameters. In the simulation, all the target parameters linearly
scale down at each time step from an initial value of xAMPA at time
0s to 0:3xAMPA at time 20s, where xAMPA represents the target
parameter values in the control condition. As shown in Fig. 14C
and Fig. 14D, the mode of the network is transited from SW back
to spindle at about 18s as a result of the decrease of AMPA
mediated excitation.
Finally, we show the effect of a combination of GABAA agonists
and AMPA antagonists. In this case, the conductances of both
GABAA and AMPA receptors are target parameters. While the
conductances of all the GABAA receptor channels scale up linearly
from xGABAA to 3xGABAA at time 20s, the conductances of all the
AMPA receptor channels scale down linearly from xAMPA to
0:3xAMPA, where xGABAA and xAMPA represents the corresponding
Figure 9. The distribution of the simulation results in terms of
oscillation frequencies and magnitudes. X-axis represents the
dominant frequency, Y-axis represents the percentage of simulations,
and different colors represent different ranges of the magnitudes of the
dominant frequency component as specified in the legend.
doi:10.1371/journal.pone.0022440.g009
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PLoS ONE | www.plosone.org 10 July 2011 | Volume 6 | Issue 7 | e22440Figure 10. Percentages of SW activities with a given synapse strength for each of the twelve synapses in the network. Y-axis
represents the percentages of SW activities. X-axis represents the relative strength of the synapse in terms of five grade levels: 1 : (0:5,0:7 x,
2 : (0:7,0:9 x, 3 : (0:9,1:1 x, 4 : (1:1,0:3 x, and 5 : (1:3,1:5 x, where x represents the corresponding maximum conductances of receptor channels in
the control condition. (A) GABAA(IN?PY). (B) GABAB(IN?PY). (C) AMPA(PY?PY). (D) AMPA(TC?PY). (E) AMPA(PY?IN). (F) AMPA(TC?IN). (G)
GABAA(RE?RE). (H) AMPA(PY?RE). (I) AMPA(TC?RE). (J) GABAA(RE?TC). (K) GABAB(RE?TC). (L) AMPA(PY?TC).
doi:10.1371/journal.pone.0022440.g010
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Fig. 14F, in this case, the mode of the network is transited from SW
backtospindle atabout10s,whichismuchearlierthantheprevious
two cases with each drug alone (17s and 20s, respectively). In fact,
the efficacy of the drug degrades significantly as the dose increases.
Two low-dose drugs with complementary receptors in combination
are likely to produce a greater therapeutic effect a larger dose of a
single drug, which will be discussed in the following sections.
Dose-response relationship. In general, the concentration
of a drug at the site of binding determines its effect. However, the
actual dependency can be complex and is often nonlinear. The
relationship between the drug dose and the response often
empirically follows the shape of a receptor binding curve, which
is described by Hill equation [46]
response(percentage)~
E
Emax
~
1
1z
EC50
Cdose
, ð1Þ
where Emax is the efficacy of a drug, which refers to the maximum
achievable response, E is the actual response achieved at a certain
dose level Cdose,a n dEC50 is the half maximal effective
concentration of the drug, which induces a response halfway
between the baseline and maximum levels after a specified exposure
time and is commonly used as a measure of the potency of a drug.
According to the above nonlinear dose-response relationship, if
the dose is 0, the response will be 0; if the dose equals to EC50, the
(percentage) response will be at 0:5; if the dose is ?, the response
will be at 1:0. Fig. 15 shows several dose-response curves with
different EC50 values.
From equation (1) , for a desired response level E, the dose
required is given by
Cdose~
EC50E
Emax{E
: ð2Þ
Optimal therapeutic treatments. The toxicity of a drug is
dose related. Furthermore, as the tests of toxicity can not be easily
performed on humans, dose of the drug is often adopted as a
metric for toxicity and it is important to reduce the dose to avoid
adverse effects. To quantitatively investigate the optimal
therapeutic treatments, we consider an optimization problem as
follows.
Given a number of N anti-epileptic drugs, the optimal
treatment Tr is defined as a combination of the drugs with the
minimal total dose such that the epilepsy can be controlled.
Tr~fCdose,1,Cdose,2,   ,Cdose,Ng is found by solving the following
optimization problem
minimize
Cdose,i
P N
i
Cdose,i
subjectto Cdose,i§0, i~1,...,N,
P
!
(Tr)[Sphysiological,
ð3Þ
where Cdose,i is the dose of the i-th drug and is an optimization
variable, P
!
is a vector of parameters characterizing the state of
patient in an n-dimensional parameter space, Sphysiological denotes
a regime of the parameter space that corresponds to the
physiological condition, P
!
(Tr) specifies the modified parameter
set after applying the treatment.
While the optimization problem (3) is general, as a demonstra-
tion, we specifically consider drugs with one of the three
complementary mechanisms of action: NaP antagonist, GABAA
agonist, and AMPA antagonist. When a drug is applied, we
assume all the target synapses/ion channels are affected to the
same degree. For example, if an AMPA antagonist is applied, the
strength of all the AMPA-mediated synapses are proportionally
reduced. As a result, the scope of the problem is limited to the
three-dimensional subspace depicted in Fig. 8.
Since the working of each drug can be complex, we model the
response of a drug by the resulted change of the corresponding
scale factor
ENap~DkNaP EGABAA~DkGABAA EAMPA~DkAMPA: ð4Þ
By the same naming convention, as shown in Fig. 8, the sets of
points in the physiological and pathological regimes are denoted by
Sphysiological and Spathological, respectively. For a given pathological
instance, (k0
Nap,k0
GABAA,k0
AMPA)[Spathological, the optimal treatment
T 
r ~Tr~fCdose,Nap,Cdose,GABAA,Cdose,AMPAgð 5Þ
is found by minimizing the total dose
minimizeCdose,NapzCdose,GABAAzCdose,AMPA ð6Þ
subjecttoCdose,Nap§0, Cdose,GABAA§0, Cdose,AMPA§0, ð7Þ
Figure 11. The joint distribution of SW activities in terms of the
strength of two critical synapses. X-axis represents the relative
strength of GABAA(IN?PY). Y-axis represents the percentage of SW
activities. Different colors represent the relative strength of AMPA(PY?PY)
as specifiedinthelegend.TherelativestrengthofbothGABAA(IN?PY) and
AMPA(PY?PY) are in terms of five grade levels: 1 : (0:5,0:7 x,2 : (0:7,0:9 x,
3 : (0:9,1:1 x, 4 : (1:1,0:3 x,a n d5 : (1:3,1:5 x,w h e r ex represents the
corresponding maximum conductances of receptor channels in the
control condition.
doi:10.1371/journal.pone.0022440.g011
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Nap{DkNaP,k0
GABAAzDkGABAA,k0
AMPA{DkAMPA)[Sphysiological,ð8Þ
Cdose,Nap~
EC50(NaP)DkNap
Emax(NaP){DkNaP
, ð9Þ
Cdose,GABAA~
EC50(GABAA)DkGABAA
Emax(GABAA){DkGABAA
, ð10Þ
Cdose,AMPA~
EC50(AMPA)DkAMPA
Emax(AMPA){DkAMPA
, ð11Þ
where Emax(Nap), Emax(GABAA), Emax(AMPA), EC50(Nap), EC50(GABAA),a n d
EC50(AMPA) are the efficacies and half maximal effective concentrations
of the three drugs, and (9), (10) (11) are based upon (2).
The parameter landscape shown in Fig. 8 provides a basis for
solving the drug optimization problem defined above. The optimal
drug treatment corresponds to the most ‘‘economical’’ way of
moving a pathological instance towards the boundary between the
pathologically and physiological regimes. In our experimental
study, the Emax values of all the drugs are set to be a number
slightly larger than the corresponding maximum scale factor of the
conductance: Emax(Nap)~1:1,E max(GABAA)~1:6,E max(AMPA)~1:6,
such that the epilepsy of all the patients in the bounded parameter
space can be controlled with a finite dose. The default values of
EC50 for all the drugs are set to be 1:0. Due to both the limitations
of the model and the simplifications made for the drug
optimization problem, the numerical optimal solutions are only
used to provide important understandings on several key issues, as
exemplified below.
Figure 12. Trajectories and phase flow representations of spindle and SW oscillations in a two-dimensional subspace. (A) Trajectory
of spindle oscillation in a 20-second simulation. (B) Phase flow representation of spindle oscillation (limit cycle). (C) Trajectory of SW oscillation in a 20-
second simulation. (D) Phase flow representation of SW oscillation (limit cycle).
doi:10.1371/journal.pone.0022440.g012
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treatments. The potency of each drug is expected to have a
significant influence on the choice of the optimal therapeutic
treatment. To more clearly see this, we use the persistent sodium
NaP antagonist to demonstrate. As the potency of a drug is often
measured by its EC50, we solve the optimization problem (6) with
decreasing values of EC50: EC50NaP~1:0, EC50NaP~0:5,
EC50NaP~0:2, EC50NaP~0:0.
The resulting optimal drug combinations are shown in Fig. 16.
Since there are three candidate drugs, the optimal treatment can
be an optimal monopharmacy solution, or a polypharmacy
combination involving more than one drug. In the figure, each
pathological instance is marked according to its optimal treatment:
GABAA agonist alone (blue circle), NaP antagonist alone (green
square), AMPA antagonist alone (black dot), and polypharmacy
(red cross).
In Fig. 16, as EC50NaP decreases, the potency of the NaP
antagonist increases. Accordingly, the number of NaP antagonist
monopharmacy based optimal treatment instances increases. The
breakdown of optimal treatments as a function of EC50NaP is
depicted in Fig. 17. From these results, it is not difficult to see the
need for developing high-potency drugs.
In addition to the issue of drug efficiency discussed above, it is
also worthy noting a related aspect, treatability. This is the best
illustrated by the results where EC50NaP~0. In this case, the
potency of the NaP antagonist is effectively infinite. However, the
set of optimal treatments does not exclusively consists of the NaP
antagonist and there is a case of AMPA antagonist as in Fig. 16D.
A detailed examination reveals that the pathological set contains
instances that are located on the plane defined by kNap~0. For
these instances, it is evident that the existence of persistent sodium
current is not the root cause for the occurrence of seizure, which is
in fact exclusively generated by the other two factors kAMPA and
kGABAA. As such, the epilepsy of patients represented by those
points cannot be controlled by suppressing INaP alone. This again
underscores the importance of correct identification of the
underlying mechanisms that are responsible for seizure generation
and personalized treatment.
Figure 13. Trajectories, phase flow representations, and field potentials of the transition from spindle to spike-and-wave. (A)
Trajectory of the transition in a 20-second simulation. (B) Phase flow representation of the transition. (C) Field potentials of the transition in a 20-
second simulation. (D) A detailed look at the transition by zooming in the field potential.
doi:10.1371/journal.pone.0022440.g013
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PLoS ONE | www.plosone.org 14 July 2011 | Volume 6 | Issue 7 | e22440Figure 14. Trajectory activities and field potentials modified by drug intervention in a 20-second simulation. (A) Trajectory activities
modified by GABAA agonists. (B) Field potentials modified by GABAA agonists. (C) Trajectory activities modified by AMPA antagonists. (D) Field
potentials modified by AMPA antagonists. (E) Trajectory activities modified by GABAA agonists and AMPA antagonists combination. (F) Field
potentials modified by GABAA agonists and AMPA antagonists combination.
doi:10.1371/journal.pone.0022440.g014
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the efficacy of polypharmacy. The nonlinearity of the dose-
response relationship also has a large impact on the choice of the
optimal treatments. Many dose-response curves follow the shape
of a receptor binding curve, where the efficacy of the drug
degrades significantly as the dose increases. For instance, the dose
Figure 15. Dose-response relationships with different EC50
values.
doi:10.1371/journal.pone.0022440.g015
Figure 16. Optimal treatments as functions of the potency of the NaP antagonist EC50NaP. (A) EC50NaP~1:0. (B) EC50NaP~0:5. (C)
EC50NaP~0:2. (D) EC50NaP~0:0.
doi:10.1371/journal.pone.0022440.g016
Figure 17. The breakdown of optimal treatments as a function
of the potency of the NaP antagonist EC50NaP.
doi:10.1371/journal.pone.0022440.g017
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ninth of that required to achieve 90% of the response. Such non-
linearity implies that two low-dose drugs with complementary
receptors in combination are likely to produce a greater
therapeutic effect with less risk of toxicity than a larger dose of a
single drug. To demonstrate this, we solve the same optimization
problem with a linear dose-response relationship, i.e.,
response~
dose
EC50
, ð12Þ
and the results are given in Fig. 18A. In this case, the number of
optimal treatments based on polypharmacy is significantly
decreased as compared with the nonlinear case shown in Fig. 18B.
This partially explains why combining drugs with different
mechanisms of action may be more beneficial in efficacy and
toxicity than a combination of drugs with similar mechanisms of
action, such as two sodium channel drugs [54]. Our optimization
results are in line with the clinical observation that polypharmacy
with drugs acting on complementary receptor sites may produce
good potentiating effect. Note that, in the analysis above, each
drug is assumed to have only one site of action. However, in
practice, even one drug can have multiple sites of action.
Therefore, the optimization results above are also in line with
the clinical observation that the most efficient drugs are the drugs
with multiple sites of action.
More broadly, there has been widespread debate about the
effect of polypharmacy for the treatment of epilepsy. As hinted
earlier, some people favor the use of multiple drugs with a lower
dose for each and believe this is more beneficial than
administrating a single high-dose drug. Our foregoing discussion
offers one possible explanation for this by attributing it to the
nonlinear dose-response characteristics of typical drugs. Other
practitioners believe that a full dose of one drug achieves better
control of seizures with fewer adverse effects. The results in Fig. 16
possibly provides a more complete picture: while monopharmacy
is often sufficient (may not be optimal) to control the epilepsy of
patents represented by points close to the boundary of the
pathological regime, polypharmacy is often more efficient for
patients with intractable epilepsy, which are represented by points
deeply inside the pathological regime. Note that our results are
obtained based upon simplifying assumptions. Polypharmacy is a
clinically complex matter. Pharmacodynamic or pharmacokinetic
drug-drug interactions may exist. To simplify the matter, we have
assumed that the effects of multiple drugs are addictive. More
complete analysis with consideration of drug-drug interactions will
be a subject of the future work when additional modeling and
experimental data is available.
Nevertheless, with the current model setup, the presented
parameter space landscape and optimization results provide
additional insights on the issue of polypharmacy. In addition to
the nonlinear dose-response relationships, the location of each
pathological instance, relative to the boundary of the pathological
and physiological regimes, plays an important role in judging the
benefit of polypharmacy. Furthermore, the distribution of patho-
logical instances provides a ‘‘view’’ of the entire patient population.
Since the distribution of patients is not uniform and more patients
are located close to the boundary,one drug may be adequate for the
majority of patients. On the other hand, rational polypharmacy
may be very beneficial for a small population of patients. These
observations are in agreement with typical clinical trials.
The variability of optimal treatments and the needs for
personalized therapy. From the above study, it is clearly seen
that the optimal therapeutic treatment varies greatly among
patients. Depending on the individual state, optimal
monopharmacy or polypharmacy may be the most desirable.
Variability is not only in terms of the choice of drugs but also in
terms of doses. Low dose may be sufficient for patients whose model
parameters are close to the boundary of the pathological and
physiological regimes whilehigh dose maybe neededforothers. It is
also possible that, due to toxicity limitation, the epileptic activities of
some patients represented by points deeply inside the pathological
regime cannot even be controlled by pharmaceutical means. In this
case, epilepsy surgery becomes necessary. In addition, although
polypharmacy may be very effective for patients deeply inside the
pathological regime, the best drug combination and the dose for
each selected drug must be carefully chosen. While many road
blockers still exist, there is clearly a need towards personalized
therapy. To achieve this goal in the future, computer models and
simulation may be leveraged to provide computational aids to help
clinicians determine the optimal treatments.
Materials and Methods
All the results in this paper are obtained with Matlab 7.1 and
the simulation can be downloaded from ModelDB(senselab.
Figure 18. The effects of linearity and nonlinearity of dose-response relationships. (A) Linear dose-response relationship. (B) Nonlinear
dose-response relationship.
doi:10.1371/journal.pone.0022440.g018
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network model in this study is similar to the one adopted in [5,7].
The network includes the single compartment representations of
four types of cells: cortical pyramidal (PY) cells, cortical
interneurons (IN), thalamic reticular (RE) cells, and thalamocor-
tical (TC) cells. The network model includes eight cells with two
cells for each type. Albeit its simplicity, the network model has
been proven to be able to make predictions for larger networks
with similar structures [7]. The single-compartment models
include intrinsic and synaptic currents described by the following
equation
Cm _ V Vi~{gL(Vi{EL){
X
j
I
ji
int{
X
k
Iki
syn, ð13Þ
where Vi is the membrane potential, Cm~1mF=cm2 is the specific
capacity of the membrane, gL is the leakage conductance, EL is
the leakage reversal potential, and intrinsic and synaptic currents
are represented by I
ji
int and Iki
syn, respectively.
Intrinsic currents Iint are modeled by kinetic models of the
Hodgkin and Huxley type [55] described by the following
equations
Iint~  g gintmNhM(V{Eint)
_ m m~am(1{m){bmm
_ h h~ah(1{h){bhh,
ð14Þ
where   g gint is the maximal conductance, and Eint is the reversal
potential. The gating properties of the current are dependent on N
activation gates and M inactivation gates, with m and h
representing the fraction of gates in open form and with respective
rate constants am, bm, ah, and bh. Rate constants are dependent on
either membrane voltage or intracellular calcium concentration.
Naz and Kz currents contribute to action potentials and are
included in all the cell models [56]. IN cells produce ‘‘fast-spiking’’
[57] firing and contain no other current than is necessary for
action potentials. For the pyramidal cells, one additional slow
voltage-dependent Kz current (IM) [58] producing ‘‘regular-
spiking’’ pattern characterized by adaptation is modeled [57].
There are T-currents in the model of thalamic cells such that
bursts of action potentials can be produced. The T-current in RE
cells ITs are of slow kinetics, which is given in [59,60]. The T-
current in TC cells IT is modeled by kinetics similar to the model
of [59] with activation considered at steady state and inactivation
described by a first order equation [5]. In addition to IT, TC cells
also include leak potassium current IKL and hyperpolarization-
activated inward current Ih [5]. We only consider the voltage
dependence of Ih and do not include the upregulation of Ih by
intracellular Ca2z which leads to wax-and-wanning properties.
Intracellular Ca2z dynamics are modeled by a simple first-order
decay with a time constant of 5ms. The equilibrium Ca2z
concentrations are 2mM extracellularly and 240nM intracellular-
ly, which corresponds to a reversal potential of 120mV [5,61].
The cell membrane areas of all cell types and the conductance
values of the corresponding intrinsic currents are as follows: for cortical
pyramidal cells, area~29000mm2, gL~0:1mS=cm2, EL~{70
mV, gNa~50mS=cm2, gK~5mS=cm2, gM~0:07mS=cm2;f o rc o r -
tical interneurons, area~14000mm2, gL~0:15mS=cm2, EL~
{70mV, gNa~50mS=cm2, gK~10mS=cm2; for thalamic re-
ticular cells, area~14000mm2, gL~0:05mS=cm2, EL~{90mV,
gNa~200mS=cm2, gK~20mS=cm2, gTs~3mS=cm2; for thalamo-
cortical cells, area~29000mm2, gL~0:01mS=cm2, EL~{70mV,
gNa~90mS=cm2, gK~10mS=cm2, gKL~3nS; gT ~2mS=cm2,
gh~0:02mS=cm2. In addition, we also add persistent current
INaP, high threshold calcium ICaH, and afterhyperpolarization
current IAPH to cortical pyramidal cells to study the roles of
intrinsic currents in the generation ofseizures. The corresponding
conductances are treated as free parameters in the exploration of
parameter space.
The synaptic current Iki
syn from presynaptic cell k to postsynaptic
cell i is simulated by activating a pulse of transmitter when cell k
fires an action potential. As shown in Fig. 1, the receptor types
present in synaptic connections are as follows: all excitatory
connections (TC? RE, TC? IN, TC? PY, PY? PY, PY? IN,
PY? RE, PY? TC) are mediated by AMPA receptors; some
inhibitory connections (RE?TC,IN?PY) are mediated by a
mixture of GABAA and GABAB receptors, whereas intra-RE
connections are mediated by GABAA receptors. In the control
condition, the receptor conductance values displaying spindle
oscillations are gAMPA(TC?RE)~0:2mS, gAMPA(PY?RE)~1:2mS,
gGABAA(RE?RE)~1mS, gGABAA(RE?TC)~0:02mS, gGABAB(RE?TC)
~0:04mS, gAMPA(PY?TC)~0:005mS, gAMPA(PY?PY)~0:6mS,
gAMPA(TC?PY)~1:2mS, gGABAA(IN?PY)~0:05mS, gGABAB(IN?PY)
~0:03mS, gAMPA(PY?IN)~0:2mS, gAMPA(TC?IN)~0:4mS.
The models of AMPA and GABAA receptors are described by
the following equation [62]
Isyn~  g gsynm(V{Esyn)
_ m m~a½T (1{m){bm,
ð15Þ
where   g gsyn is the maximal conductance, m is the fraction of the
open receptors, Esyn is the reversal potential, ½T  is the transmitter
concentration in the cleft, and a and b are forward and backward
binding rate constants of T to open the receptors. The parameters
used are as follows: Esyn~0mV, a~0:94|106M{1s{1,
b~180s{1 for AMPA receptors and Esyn~{80mV, a~20|
106M{1s{1, b~160s{1 for GABAA receptors.
Due to the nonlinear property, the models of GABAB receptors
are described by different equations [63]
IGBABB~  g gGBABB
snzKD
sn (V{EK)
_ r r~K1½T (1{r){K2r
_ s s~K3r{K4s,
ð16Þ
where ½T  is the GABA concentration in the synaptic cleft, r is the
fraction of GABAB receptors in the activated form, s is the
normalized G-protein concentration in activated form,   g gGABAB is
the maximal postsynaptic conductance of Kz channels, KD is the
dissociation constant of G-protein binding on Kz channels, V is
the postsynaptic membrane potential, and EK is the equilibrium
potential for Kz. The parameters are as follows: KD~100,
K1~9|104M{1s{1, K2~1:2s{1, K3~180s{1, andK4~34s{1,
with n~4 binding sites.
The field potentials (EEG) are simulated based on postsynaptic
and intrinsic currents of the two pyramidal cells
Ce _ V Veeg~{
Veeg
Re
z(
X
Iint(PY)z
X
Isyn(PY)) ð17Þ
where Veeg represents the field potentials (EEG waveforms), P
Isyn(PY) represents the sum of postsynaptic currents of the two
PY cells,
P
Iint(PY) represents the sum of intrinsic currents of the
two PY cells, Re and Ce represent the resistance and capacitance
of extracellular media and EEG equipment, which behave like
Integration of Epileptic Mechanism and Implication
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Naz and Kz currents for action potentials generation as they
make little contribution to the EEG [64].
Generally, if there are N pyramidal cells in the model, the field
potential should be computed based on N pyramidal cells (a
weighed sum of currents of the PY cells and the weight is
determined by the distance between each PY cell and the position
where the field potential is measured). In this paper, there are only
two PY cells in the eight cell model. The sum of currents from the
two PY cells corresponds to the field potential measured in a
position with equal distance from each PY cell.
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